Skip to main content
. 2022 Feb 4;14(3):664. doi: 10.3390/nu14030664

Table 2.

Primary and secondary outcomes according to the modified intention-to-treat analysis.

Intermittent Feeding
(n = 49)
Continuous Feeding
(n = 50)
Relative Risk
(95% CI)
p-Value
Primary outcome
≥80% of the target requirement, achievement days/total days of feeding (%) 119/227 (52.4) 147/226 (65.0) 1.24 (1.06–1.45) 0.008
Secondary outcomes
ICU mortality, n (%) 24 (49.0) 16 (32.0) 0.65 (0.40–1.07) 0.129
Death within 28 days, n (%) 26 (53.1) 21 (42.0) 0.79 (0.52–1.20) 0.368
Median length of hospital stay (IQR), days
In-hospital survivors 25 (17–33) 22 (11–38) 0.763
In-hospital nonsurvivors 9 (4–15) 10 (6–19) 0.603
Median length of ICU stay (IQR), days
ICU survivors 8 (5–11) 6 (3–11) 0.443
ICU nonsurvivors 6 (3–10) 7 (4–12) 0.782
Gastrointestinal intolerance, n (%)
Diarrhea 22 (44.9) 22 (44.0) 0.98 (0.63–1.52) >0.999
Constipation 22 (44.9) 28 (56.0) 1.25 (0.84–1.85) 0.366
Vomiting or regurgitation 8 (16.3) 7 (14.0) 0.86 (0.34–2.18) 0.966
Abdominal pain or distension 8 (16.3) 3 (6.0) 0.37 (0.10–1.30) 0.189
Aspiration 0 (0) 2 (4.0) 4.90 (0.24–99.57) 0.484
Received prokinetic drugs 12 (24.5) 19 (38.0) 1.55 (0.85–2.84) 0.218
Days without mechanical ventilation a 0 (0–20) 11 (0–20) 0.142
Days without dialysis a 11 (0–28) 24 (7–28) 0.077
Days without vasopressor support a 11 (0–24) 19 (4–26) 0.062

a The number of days alive and free from mechanical ventilation, dialysis, and vasopressor support were calculated for the first 28 study days. CI = confidence interval; ICU = intensive care unit; IQR = interquartile range.